Compare QXO Inc. Common Stock (QXO) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
QXO Inc. Common Stock vs Tenet Healthcare Corporation — how do they compare? QXO Inc. Common Stock trades at $10.51 (market cap $10.72B), while Tenet Healthcare Corporation trades at $277.39 (market cap $21.87B). The key difference: Tenet Healthcare Corporation is far larger — about 2× QXO Inc. Common Stock's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, QXO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold QXO Inc. Common Stock for 0 Days and Tenet Healthcare Corporation for 16 Days on average.
| QXO | THC | |
|---|---|---|
Market Cap | $10.72B | $21.87B |
Volume | 34,000,619 | 717,275 |
Sector | Industrials | Health |
52-Week High | $27.07 | $280.77 |
52-Week Low | $10.33 | $161.37 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $16.04B | $32.95B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Tenet Healthcare (THC) trades at $266.91, down 0.69% on the day, with strong fundamental performance including three consecutive quarterly earnings beats. The stock maintains bullish technical signals with key support at $265 and resistance at $271. Revenue growth continues despite softer surgical volumes, driven by higher revenue per case and favorable service mix. Analyst consensus remains overwhelmingly positive with 81% buy ratings and a $283.36 price target representing 6% upside potential.
THC presents a compelling investment case with attractive valuation metrics (P/E 10.5, EV/EBITDA 5.91) and strong profitability (ROE 53.31%, net margin 9.9%). The company's expanding capital-return strategy is supported by robust cash flow, though growth investments and capital needs require monitoring. Key risks include execution challenges and healthcare regulatory uncertainty, but the fundamental outlook remains positive with expected revenue growth to $22.6B and net profit margin expansion to 9.89% in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About QXO Inc. Common Stock
QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
